Last reviewed · How we verify

oral vancomycin and oral amoxicillin

University of Minnesota · Phase 1 active Small molecule Quality 0/100

oral vancomycin and oral amoxicillin is a Small molecule drug developed by University of Minnesota. It is currently in Phase 1 development.

At a glance

Generic nameoral vancomycin and oral amoxicillin
SponsorUniversity of Minnesota
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about oral vancomycin and oral amoxicillin

What is oral vancomycin and oral amoxicillin?

oral vancomycin and oral amoxicillin is a Small molecule drug developed by University of Minnesota.

Who makes oral vancomycin and oral amoxicillin?

oral vancomycin and oral amoxicillin is developed by University of Minnesota (see full University of Minnesota pipeline at /company/university-of-minnesota).

What development phase is oral vancomycin and oral amoxicillin in?

oral vancomycin and oral amoxicillin is in Phase 1.

Related